Blood‐based detection of lung cancer using cysteine‐rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study

Lung cancer is the most often diagnosed cancer and the main cause of cancer deaths in the world compared with other tumor entities. To date, the only screening method for high‐risk lung cancer patients is low‐dosed computed tomography which still suffers from high false‐positive rates and overdiagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Ac\ˇkar, Lucija, Casjens, Swaantje, Andreas, Antje, Raiko, Irina, Brüning, Thomas, Geffken, Maria, Peine, Sven, Kollmeier, Jens, Johnen, Georg, Bartkowiak, Kai, Weber, Daniel Gilbert, Pantel, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564649/
https://www.ncbi.nlm.nih.gov/pubmed/34510714
http://dx.doi.org/10.1002/1878-0261.13099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564649/
https://www.ncbi.nlm.nih.gov/pubmed/34510714
http://dx.doi.org/10.1002/1878-0261.13099

Ejemplares similares